Compared to other major orthopedic markets, the Japanese trauma device market will be somewhat less severely impacted by the COVID-19 pandemic given the urgent nature of many trauma cases. Once the market stabilizes, favorable demographics will support procedure volume expansion, however, overall revenue growth will be hindered by falling ASPs—reflecting biennial MHLW reimbursement cuts—as well as slower entry of premium-priced devices relative to other mature markets globally, and the possible introduction of a cost-effectiveness–based reimbursement pricing system.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for trauma devices in Japan across a 10-year period.
The COVID-19 pandemic will affect the trauma device market.
To what extent will COVID-19 impact the trauma device market in Japan?
How quickly are procedure volumes expected to recover?
MNCs dominate the Japanese trauma device market.
Which MNCs have the strongest presence in the Japanese market?
What strategies and factors will contribute to success in this region through 2028?
Biennial MHLW reimbursement cuts will continue to negatively affect the Japanese trauma device market.
Which segments will be most severely impacted by MHLW reimbursement cuts?
What strategies will companies use to increase their market share despite reimbursement cuts in the Japanese trauma device market?
The Japanese market possesses unique dynamics that make it different from trauma device markets in other countries or regions.
What market drivers and limiters are unique to Japan, and how are these factors affecting the various market segments?
How should manufacturers respond to these market forces to bolster their positions in the Japanese trauma device market?
In spite of the complicated regulatory environment, some competitors possess advantages due to their knowledge of the domestic marketplace or can leverage their success in other markets.
Which competitors are best poised for success going forward?
How does the regulatory system affect current and future market revenues for companies in this space?
- Trauma Devices - Market Insights - Japan
Author(s): Diwakar Bahuguna, MBA
Diwakar Bahuguna is a senior analyst within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Decision Resources Group, specializing in hyaluronic acid viscosupplementation and Latin American aesthetic injectables markets. Diwakar holds a Bachelor's degree in Pharmacy from the University of Delhi and an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, Mohali.
Follow Diwakar on twitter: @diwakar_zero7